PHARMAC is taking more time to consider all the feedback it has received on a proposal to fund empagliflozin (with or without metformin) and dulaglutide for New Zealanders with type 2 diabetes
A 24-year longitudinal study of 45,000 south Auckland patients estimates there are almost 19,000 extra deaths annually among Māori with type 2 diabetes
All seven Auckland PHOs and Diabetes Foundation Aotearoa have attacked Pharmac’s drug funding proposal for new diabetes drugs, claiming restrictions will hurt Māori and Pasifika
Pharmac is standardising the way medicines are contracted, providing better support to healthcare professionals when they are prescribing medicines for their patients
Diabetes Foundation Aotearoa says Pharmac’s plan for very limited funding for Type 2 diabetes drugs has met strong and unusual resistance from the medical establishment
In an open letter to the prime minister and health minister, more than 100 specialists label Pharmac’s handling of severe inflammatory bowel disease drug funding “deeply flawed” and based on “false assumptions” – Pharmac disagrees
As millions of pharmacists celebrate the 10th anniversary of World Pharmacists Day tomorrow, Pharmac's chief executive Sarah Fitt acknowledges the extraordinary work done by New Zealand pharmacists and pharmacy staff this year
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management